6838 台新藥 / 融資融券(季)
融資融券統計
| 11/16 資券狀況 | 2026年統計資料 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
率 | 互抵 | 當沖 | 餘額 | 張數 | 率 | 張數 | 張數 | ||||||||
| 0 | 1,520 | +644 | +42.4% | 2,999 (04/08) | 1,544 (01/02) | ||||||||||
| 10 | -10 | -100% | 19 (04/09) | 0 (02/23) | |||||||||||
資券累計增減統計
11/13 ~11/16 | 11/12 ~11/16 | 11/10 ~11/16 | 11/03 ~11/16 | 10/19 ~11/16 | 08/18 ~11/16 | 05/19 ~11/16 | '25/11/17 ~11/16 | |||
|---|---|---|---|---|---|---|---|---|---|---|
(增減幅) | -30 (-1.37%) | -30 (-1.37%) | -31 (-1.41%) | -48 (-2.17%) | -51 (-2.3%) | -388 (-15.2%) | -677 (-23.83%) | +924 (+74.52%) | - | - |
(增減幅) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | -13 (-100%) | -10 (-100%) | - | - |
(增減幅) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | -4 (-100%) | -100 (-100%) | -1,940 (-100%) | - | - |
| 0 | 0 | 0 | 0 | 0 | 0 | -0.46 | -0.81 | - | - |
(%) | (千張) | 互抵 (千張) | 當沖 (%) | 比 (%) | 當沖 (%) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
率% | 率% | |||||||||||||||||||
| 26Q4 | 4.11 | 0 | 0.06 | 0.02 | -0.08 | 2.16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| 26Q3 | 9.09 | 0 | 0.12 | 0.32 | -0.43 | 2.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| 26Q2 | 16.6 | 1.25 | 0.62 | 0.09 | +0.54 | 2.68 | 0.02 | 0.02 | 0 | -0.01 | 0 | 0.01 | 0.05 | 0 | 33.3 | |||||
| 26Q1 | 18.3 | 1.97 | 1.33 | 0.04 | +0.61 | 2.13 | 5.64 | 0.05 | 0.04 | 0 | 0 | 0.01 | 0.02 | 0.02 | 0.09 | 0.33 | 25.1 | |||
| 25Q4 | 12.2 | 0.88 | 0.59 | 0.04 | +0.24 | 1.52 | 4.03 | 0 | 0 | 0 | 0 | 0.01 | 0.03 | 0 | 0.01 | 0.66 | 22.9 | |||
| 25Q3 | 38.4 | 2.45 | 2.68 | 0.04 | -0.27 | 1.28 | 3.38 | 0.22 | 0.09 | 0.01 | -0.13 | 0.01 | 0.03 | 0.02 | 0.05 | 0.86 | 37.1 | |||
| 25Q2 | 127 | 7.51 | 6.43 | 0.01 | +1.06 | 1.54 | 4.09 | 0.28 | 0.43 | 0.01 | +0.14 | 0.14 | 0.38 | 0.24 | 0.19 | 9.33 | 56.7 | |||
| 25Q1 | 20.1 | 1.25 | 0.76 | 0 | +0.48 | 0.48 | 1.27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 30.1 | |||
| 24Q4 | 26.9 | |||||||||||||||||||
| 24Q3 | 41.1 | |||||||||||||||||||

